Provider review
MEDVi tirzepatide review
MEDVi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
Updated 2026-09-18 · Public-source editorial · See dated evidence below
MEDVi offers compounded tirzepatide as both a weekly injection and a tablet, and publishes the price of only one of them.
Injections are listed at $399 a month, consistent between the first month and renewals, which is at least honest. Tablet pricing is quoted only after you have completed the intake questionnaire — meaning you hand over health information before you learn what it costs.
Recorded costs and what to confirm
| Comparison step | Tirzepatide at MEDVi |
|---|---|
| Earlier figures | Dated cost record |
| Treatment | Name the product, route, prescribed amount and supply period |
| First payment | Itemize medicine, care, tests, supplies and delivery |
| Renewal | Give the next charge, its date and the supply it covers |
| Change or exit | Explain remaining charges and any refund before payment |
Consistent month to month, but high.
At $399 a month, a year runs roughly $4,788. That is approximately double Coreage Rx month-to-month and triple its annual plan, for the same class of compounded product.
How MEDVi works
Compounded GLP-1 provider offering weekly injections and a tablet formulation, with tablet pricing quoted after intake rather than published.
The injection programme is conventional and competently run. Pricing does not jump after month one, which is more than several competitors manage. The tablet option is genuinely useful for needle-averse patients, assuming you are willing to complete intake to find out what it costs.
The earlier source record
- Compounded tirzepatide injections listed at $399/month.
- Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.
The underlying record is dated 2026-09-18. Its amounts, plan details and service descriptions are historical. Confirm the exact product, billing interval, included services and renewal terms before using a figure as a budget.
Where it is strong
- Injection pricing is consistent between the first month and renewals.
- Tablet option for people who will not inject.
Where it falls short
- Tablet pricing is withheld until after you have handed over health information.
- $399/month is roughly double the flat-rate leaders.
The thing most people miss
You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.
How it scored
The historical rubric gives MEDVi 2.8 out of 5. Display position 23 of 23 also reflects commercial placements; it is not a clinical quality rank. These scores have not been independently revalidated. See how we rate.
| What we weigh | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 2.4 / 5 |
| Price honesty | 20% | 2.5 / 5 |
| Clinical support | 20% | 3.3 / 5 |
| Pharmacy sourcing | 15% | 3.2 / 5 |
| Cancelling | 15% | 3 / 5 |
Who it suits
Reasonable for someone who wants a tablet option and does not mind the intake-first pricing. Hard to justify for a straightforward weekly injection.
Our verdict
Consistent pricing on the injection, withheld pricing on the tablet, and a figure that is high either way. Ask for the tablet price in writing before you start.
How it compares on tirzepatide
| # | Provider | Cost record | Compare a new quote | Historical score |
|---|---|---|---|---|
| 1 | Coreage Rx Featured | Dated cost record | Product, supply, fees and renewal | 4.5 |
| 2 | SuperHealthy Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 3 | Likeness Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 4 | Trimi | Dated cost record | Product, supply, fees and renewal | 4.6 |
| 5 | PlexusDx | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 6 | Ozari Health | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 7 | Fifty 410 | Dated cost record | Product, supply, fees and renewal | 4.2 |
| 8 | Ivím Health | Dated cost record | Product, supply, fees and renewal | 4 |
| 9 | Mochi Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 10 | Coby Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 11 | Hims & Hers | Dated cost record | Product, supply, fees and renewal | 3.5 |
| 12 | Ro | Dated cost record | Product, supply, fees and renewal | 3.5 |
The full reasoning behind this order is in our best tirzepatide providers guide.
Read next
- Coreage Rx tirzepatide review
Coreage Rx tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Likeness Rx semaglutide review
Likeness Rx semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Trimi tirzepatide review
Trimi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- The best tirzepatide providers in 2026
23 historical provider records, with cost-component questions, clinical evidence limits and commercial placements explained.
- Tirzepatide vs semaglutide
One trial put them head to head. The result was not close — but the cheaper drug still wins for some people.
- How to Compare GLP-1 Costs: Fees, Refills and Renewal
Separate medication, care fees, supply duration, prepayment and renewal when comparing a GLP-1 quote.
Coreage Rx pays us a commission on sign-ups through our links. Commercial placements affect display order; the tables are not clinical recommendations. How we rate · Disclosure
